Onclive.com / Incontinence



Domain overview in Incontinence niche. Based on relevant links and pages only.
onclive.com rank
873
Number of domains linking to onclive.com
2
semantic flow
0.01
Number of links to onclive.com
5
semantic flow
0.01
Number of domains linked from onclive.com
1
semantic flow
0
Number of links from onclive.com
1
semantic flow
0

Popular pages pointing to onclive.com

Pages with highest topical PageRank pointing to domain.

url / atext / target url
http://www.onclive.com/conference-coverage/sgo-winter-2018/dr-backes-on-pelvic-exenteratio
terms conditions
http://www.onclive.com/conference-coverage/sgo-winter-2018/terms
http://www.onclive.com/
dr backes on pelvic exenteration surgery in gynecologic cancer
http://www.onclive.com/conference-coverage/sgo-winter-2018/dr-backes-on-pelvic-exenteratio
http://www.onclive.com/conference-coverage/gu-2018/dr-bellmunt-discusses-followup-data-for
robotic approaches advancing surgical scope in muscle invasive bladder cancer
http://www.onclive.com/web-exclusives/robotic-approaches-advancing-surgical-scope-in-muscl
http://www.onclive.com/conference-coverage/gu-2018/dr-bellmunt-discusses-followup-data-for
organ preservation approaches in muscle invasive bladder cancer
http://www.onclive.com/web-exclusives/organ-preservation-approaches-in-muscleinvasive-blad
http://www.onclive.com/peer-exchange-archive/squamous-nsclc/immune-checkpoint-inhibitors-i
terms conditions
http://www.onclive.com/peer-exchange-archive/squamous-nsclc/terms
http://www.onclive.com/web-exclusives/robotic-approaches-advancing-surgical-scope-in-muscl
fda approves abiraterone for high risk prostate cancer
http://www.onclive.com/web-exclusives/fda-approves-abiraterone-acetate-plus-adt-for-highri
http://www.onclive.com/web-exclusives/robotic-approaches-advancing-surgical-scope-in-muscl
precision medicine in oncology sup sup precision medicine in oncology
http://www.onclive.com/specialty/cancer-pathways
http://www.onclive.com/web-exclusives/robotic-approaches-advancing-surgical-scope-in-muscl
sm 88 delays recurrence for nonmetastatic prostate cancer
http://www.onclive.com/conference-coverage/gu-2018/sm88-delays-recurrence-for-nonmetastati

Popular pages from onclive.com

On-topic pages from domain with highest topical PageRank.

title / url
PR


info
relevance


info
links


info
rel links


info
external links


info
external domains


info
referring domains


info
external backlinks


info
Organ Preservation Approaches in Muscle-Invasive Bladder Cancer
http://www.onclive.com/web-exclusives/organ-preservation-approaches-in-muscleinvasive-blad
0.210.94100222200
Robotic Approaches Advancing Surgical Scope in Muscle-Invasive Bladder Cancer
http://www.onclive.com/web-exclusives/robotic-approaches-advancing-surgical-scope-in-muscl
0.210.87100222200

Domains with most semantic flow to onclive.com

Relevant domains with most links to selected domain.

domain info
count


info
semantic flow


info
http://zerocancer.org/ 40.01zerocancer.org
http://ucla.edu/ 10ucla.edu

Domains with most semantic flow from onclive.com

Relevant domains with most links from selected domain.

domain info
count


info
semantic flow


info
http://giantsofcancercare.com/ 10giantsofcancercare.com

Most linked pages from onclive.com

Pages from domain with most relevant inbound links.

url
count


info
PR


info
score


info
semantic flow


info
relevance


info
on topic


info
links


info
rel links


info
external links


info
external domains


info
referring domains


info
external backlinks


info
http://www.onclive.com/publications/urologists-in-cancer-care/2015/august-2015/terms 10.160.540.01-1--1-1-1-100
http://www.onclive.com/specialty/colorectal-cancer 10.160.850.01-1no-1-1-1-100
http://www.onclive.com/specialty/prostate-cancer 10.160.880.01-1no-1-1-1-100
http://www.onclive.com/specialty/patients 10.160.880.01-1no-1-1-1-100
http://www.onclive.com/specialty/lung-cancer 10.160.860.01-1no-1-1-1-100
http://www.onclive.com/specialty/metastatic-crpc 10.160.820.01-1no-1-1-1-100
http://www.onclive.com/web-exclusives/accurate-risk-status-assessment-critical-to-prostate 10.150.410-1--1-1-1-111
http://www.onclive.com/web-exclusives/patnaik-highlights-evolution-toward-immunotherapy-in 10.150.340-1--1-1-1-111
http://www.onclive.com/web-exclusives/psychological-effects-from-adt-a-growing-challenge-i 10.150.280-1--1-1-1-111
http://www.onclive.com/publications/urologists-in-cancer-care/2015/august-2015/start-discu 10.170.150-1no-1-1-1-111

Hubs from onclive.com

Pages from domain with most likely on-topic outgoing links.

url
count


info
PR


info
score


info
semantic flow


info
relevance


info
on topic


info
links


info
rel links


info
external links


info
external domains


info
referring domains


info
external backlinks


info
http://www.onclive.com/publications/urologists-in-cancer-care/2015/august-2015/start-discu 170.170.150.11-1no-1-1-1-111
http://www.onclive.com/specialty/prostate-cancer 50.160.880.01-1no-1-1-1-100
http://www.onclive.com/specialty/genitourinary-cancer 50.160.880.01-1no-1-1-1-100
http://www.onclive.com/specialty/personalized-medicine 40.160.870.01-1no-1-1-1-100
http://www.onclive.com/specialty/gastrointestinal-cancer 20.160.850-1no-1-1-1-100
http://www.onclive.com/specialty/lung-cancer 20.160.860-1no-1-1-1-100
http://www.onclive.com/specialty/brain-cancer 20.160.860-1no-1-1-1-100
http://www.onclive.com/specialty/metastatic-crpc 10.160.820-1no-1-1-1-100
http://www.onclive.com/publications/urologists-in-cancer-care 10.160.530-1no-1-1-1-100
http://www.onclive.com/specialty/patients 10.160.880-1no-1-1-1-100

contact | terms | privacy
© 2018-2024 semanticjuice.com